Ultragenyx Pharmaceutical Inc. buy Robert W. Baird
Start price
30.12.25
/
50%
€17.00
Target price
30.12.26
€39.91
Performance (%)
6.47%
Price
31.03.26
€16.90
Summary
This prediction is currently active. With a performance of 6.47%, the BUY prediction by Robert_W__Baird for Ultragenyx Pharmaceutical Inc. is trending in the right direction. This prediction currently runs until 30.12.26. The prediction end date can be changed by Robert_W__Baird at any time. Robert_W__Baird has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | -1.170% | -1.170% |
| iShares Core DAX® | 1.604% | -7.448% |
| iShares Nasdaq 100 | -0.734% | -1.864% |
| iShares Nikkei 225® | 1.296% | -6.795% |
| iShares S&P 500 | -0.394% | -2.336% |
Comments by Robert_W__Baird for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical (NASDAQ:RARE) had its price target lowered by analysts at Robert W. Baird from $72.00 to $47.00. They now have an "outperform" rating on the stock.
Ratings data for RARE provided by MarketBeat
Stopped prediction by Robert_W__Baird for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€36.00
31.05.24
31.05.24
€66.15
31.05.25
31.05.25
-17.78%
01.06.25
01.06.25
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€40.80
30.01.24
30.01.24
€62.74
30.01.25
30.01.25
1.96%
31.01.25
31.01.25